1. Home
  2. PSTV vs CREG Comparison

PSTV vs CREG Comparison

Compare PSTV & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • CREG
  • Stock Information
  • Founded
  • PSTV 1996
  • CREG 1980
  • Country
  • PSTV United States
  • CREG China
  • Employees
  • PSTV N/A
  • CREG N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • CREG Power Generation
  • Sector
  • PSTV Health Care
  • CREG Utilities
  • Exchange
  • PSTV Nasdaq
  • CREG Nasdaq
  • Market Cap
  • PSTV 7.9M
  • CREG 6.7M
  • IPO Year
  • PSTV N/A
  • CREG N/A
  • Fundamental
  • Price
  • PSTV $1.18
  • CREG $0.71
  • Analyst Decision
  • PSTV Strong Buy
  • CREG
  • Analyst Count
  • PSTV 2
  • CREG 0
  • Target Price
  • PSTV $14.00
  • CREG N/A
  • AVG Volume (30 Days)
  • PSTV 111.7K
  • CREG 164.9K
  • Earning Date
  • PSTV 11-14-2024
  • CREG 11-08-2024
  • Dividend Yield
  • PSTV N/A
  • CREG N/A
  • EPS Growth
  • PSTV N/A
  • CREG N/A
  • EPS
  • PSTV N/A
  • CREG N/A
  • Revenue
  • PSTV $5,725,000.00
  • CREG N/A
  • Revenue This Year
  • PSTV $11.13
  • CREG N/A
  • Revenue Next Year
  • PSTV N/A
  • CREG N/A
  • P/E Ratio
  • PSTV N/A
  • CREG N/A
  • Revenue Growth
  • PSTV 52.63
  • CREG N/A
  • 52 Week Low
  • PSTV $1.15
  • CREG $0.63
  • 52 Week High
  • PSTV $2.67
  • CREG $2.00
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 40.01
  • CREG 45.84
  • Support Level
  • PSTV $1.16
  • CREG $0.68
  • Resistance Level
  • PSTV $1.42
  • CREG $0.72
  • Average True Range (ATR)
  • PSTV 0.11
  • CREG 0.04
  • MACD
  • PSTV -0.01
  • CREG 0.00
  • Stochastic Oscillator
  • PSTV 6.06
  • CREG 44.22

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company currently offer waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

Share on Social Networks: